Saturday, July 27, 2013

Drug-eluting stents, heart attack and bleeding risks: One-year results of ADAPT-DES trial

[unable to retrieve full-text content]Patients who receive a drug-eluting stent and demonstrate high platelet reactivity on clopidogrel are more likely to have blood clots form on the stent and to suffer a heart attack; however, these patients are less likely to develop bleeding complications.

Source: http://feeds.sciencedaily.com/~r/sciencedaily/~3/9ckAC2wlXdY/130726112207.htm

buffalo bills st louis rams ryan tannehill pittsburgh steelers seattle seahawks space shuttle new york courtney upshaw

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.